Established in 2018, Applied Cells has been at the forefront of cell therapy manufacturing, and cell separation technology, collaborating closely with global medical and industrial experts. Our pioneering MARS technologies, including MARS Bar and MARS Atlas, have enabled rapid and low cost (<$10k USD) CAR-T manufacturing in less than 72 hours. At the same time, MARS utilization in MRD enrichment has enabled 100x better resolution in detection of residual tumor cells that further enabled early prevention of cancer relapse in breast cancer and multiple myeloma. MARS technology offers extremely simplified workflow, at a much lower cost, with a better outcome of cell therapy applications and cancer detection applications. These revolutionary approaches have been adopted by leading cancer centers and industrial partners in their clinical trials and CLIA offerings.